Samsung BioLogics Co (XKRX:207940) Total Tax Payable : ₩375,388 Mil (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Samsung BioLogics Co Total Tax Payable?

Samsung BioLogics Co's Total Tax Payable for the quarter that ended in Dec. 2024 was ₩375,388 Mil.

Samsung BioLogics Co's quarterly Total Tax Payable increased from Jun. 2024 (₩192,843 Mil) to Sep. 2024 (₩281,065 Mil) and increased from Sep. 2024 (₩281,065 Mil) to Dec. 2024 (₩375,388 Mil).

Samsung BioLogics Co's annual Total Tax Payable declined from Dec. 2022 (₩223,299 Mil) to Dec. 2023 (₩191,212 Mil) but then increased from Dec. 2023 (₩191,212 Mil) to Dec. 2024 (₩375,388 Mil).

Samsung BioLogics Co Total Tax Payable Historical Data

The historical data trend for Samsung BioLogics Co's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samsung BioLogics Co Total Tax Payable Chart

Samsung BioLogics Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Tax Payable

Get a 7-Day Free Trial

23,259.66

110,174.30

223,298.68

191,211.78

375,387.99

Samsung BioLogics Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Tax Payable	Get a 7-Day Free Trial															191,211.78	235,609.24	192,842.79	281,065.40	375,387.99

Samsung BioLogics Co Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Samsung BioLogics Co Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Samsung BioLogics Co's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Samsung BioLogics Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Samsung BioLogics Co Ltd (XKRX:207940) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

125, Cheomdan-daero, Yeonsu-gu, Incheon, KOR

Website

https://www.samsungbiologics.com

Founded in 2011, Samsung Biologics is a South Korean contract development and manufacturing organization with a global client base. Europe and the US contribute 90% of its total revenue. It provides end-to-end development and manufacturing services from cell line developments to final commercial manufacturing. As of 2023, Samsung Biologics had a total production capacity of 604,000 liters, one of the largest in the world. Its CDMO services account for 72.4% of its total revenue. The balance comes from subsidiary Samsung Bioepis, acquired in 2022. Samsung Bioepis is involved in developing and manufacturing biosimilars.

Samsung BioLogics Co Headlines

No Headlines